IL1B and Parkinson disease: Immunomodulatory effects on the increased levels of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, and IFN-γ) have been observed in the Parkinson’s patient brains with a large number of proliferating activated immune cells [50].